ConductScience.org, home

Paper41201971

T2R5 Agonist Phendione Decreases Cell Viability and Induces Apoptosis in Head and Neck Squamous Cell Carcinoma.

Sywanycz S and 7 others. Mol Cancer Ther, 2026. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. T2R5 Agonist Phendione Decreases Cell Viability and Induces Apoptosis in Head and Neck Squamous Cell Carcinoma. Papers, record 41201971. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41201971

Download JSON
Cell line
FaDu129 papers
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
T2R5 Agonist Phendione Decreases Cell Viability and Induces Apoptosis in Head and Neck Squamous Cell Carcinoma.
PubMed
Journal
Mol Cancer Ther
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-09-20
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ApoptosisMajor topic
Squamous Cell Carcinoma of Head and NeckMajor topic
Receptors, G-Protein-CoupledMajor topic
Head and Neck NeoplasmsMajor topic
Humans
Cell Survival
Cell Line, Tumor
Taste Receptors, Type 2
Animals
Mice
Xenograft Model Antitumor Assays
Cell Proliferation

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 AI167971NIAID NIH HHSUnited StatesR01AI167971PubMedNIH RePORTER
R01 DE034474NIDCR NIH HHSUnited StatesR01DE034474PubMedNIH RePORTER
1R01DE034474National Institute of Dental and Craniofacial Research (NIDR)R01DE034474PubMedNIH RePORTER
R01AI167971National Institute of Allergy and Infectious Diseases (NIAID)R01AI167971PubMedNIH RePORTER

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Update of40462977T2R5 agonist phendione decreases cell viability and induces apoptosis in head and neck squamous cell carcinoma.https://conductscience.org/library/papers/40462977

Source PubMed

Download CSV of comments and corrections

References90

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126416778Anti-Pseudomonas aeruginosa activity of 1,10-phenanthroline-based drugs against both planktonic- and biofilm-growing cells.J Antimicrob Chemother2016https://conductscience.org/library/papers/26416778PubMed
234503172Apoptosis Deregulation and the Development of Cancer Multi-Drug Resistance.Cancers (Basel)2021https://conductscience.org/library/papers/34503172PubMed
323050025Bioactive phytochemical proanthocyanidins inhibit growth of head and neck squamous cell carcinoma cells by targeting multiple signaling molecules.PLoS One2012https://conductscience.org/library/papers/23050025PubMed
432172302Bitter taste receptors stimulate phagocytosis in human macrophages through calcium, nitric oxide, and cyclic-GMP signaling.Cell Mol Life Sci2021https://conductscience.org/library/papers/32172302PubMed
534542294Structures and Agonist Binding Sites of Bitter Taste Receptor TAS2R5 Complexed with Gi Protein and Validated against Experiment.J Phys Chem Lett2021https://conductscience.org/library/papers/34542294PubMed
633344890Identification and Characterization of Novel Bronchodilator Agonists Acting at Human Airway Smooth Muscle Cell TAS2R5.ACS Pharmacol Transl Sci2020https://conductscience.org/library/papers/33344890PubMed
724959857Genetically-encoded yellow fluorescent cAMP indicator with an expanded dynamic range for dual-color imaging.PLoS One2014https://conductscience.org/library/papers/24959857PubMed
823311874Different phenolic compounds activate distinct human bitter taste receptors.J Agric Food Chem2013https://conductscience.org/library/papers/23311874PubMed
924396730Minireview: Targeting GPCR Activated ERK Pathways for Drug Discovery.Curr Chem Genom Transl Med2013https://conductscience.org/library/papers/24396730PubMed
1028053191Extraoral bitter taste receptors in health and disease.J Gen Physiol2017https://conductscience.org/library/papers/28053191PubMed
1133602906Cell death in head and neck cancer pathogenesis and treatment.Cell Death Dis2021https://conductscience.org/library/papers/33602906PubMed
1234496302Pharmacological significance of extra-oral taste receptors.Eur J Pharmacol2021https://conductscience.org/library/papers/34496302PubMed
1315087236Receptors for bitter, sweet and umami taste couple to inhibitory G protein signaling pathways.Eur J Pharmacol2004https://conductscience.org/library/papers/15087236PubMed
1421376230Hallmarks of cancer: the next generation.Cell2011https://conductscience.org/library/papers/21376230PubMed
1529800964Patterns of Tobacco Cessation Attempts and Symptoms Experienced Among Smokers With Head and Neck Squamous Cell Carcinoma.JAMA Otolaryngol Head Neck Surg2018https://conductscience.org/library/papers/29800964PubMed
1635107858Functional and genomic comparative study of the bitter taste receptor family TAS2R: Insight into the role of human TAS2R5.FASEB J2022https://conductscience.org/library/papers/35107858PubMed
1731632299Bitter Taste Receptors (TAS2Rs) in Human Lung Macrophages: Receptor Expression and Inhibitory Effects of TAS2R Agonists.Front Physiol2019https://conductscience.org/library/papers/31632299PubMed
1822621925Complex cisplatin-double strand break (DSB) lesions directly impair cellular non-homologous end-joining (NHEJ) independent of downstream damage response (DDR) pathways.J Biol Chem2012https://conductscience.org/library/papers/22621925PubMed
1939946435TAS2R5 screening reveals biased agonism that fails to evoke internalization and downregulation resulting in attenuated desensitization.PLoS One2025https://conductscience.org/library/papers/39946435PubMed
207615510Distinct pathways of Gi- and Gq-mediated mitogen-activated protein kinase activation.J Biol Chem1995https://conductscience.org/library/papers/7615510PubMed

See all 90 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
42033132Cigarette Smoke Exposure Attenuates T2R-Mediated Apoptosis in Head and Neck Squamous Cell Carcinoma.Head Neck2026https://conductscience.org/library/papers/42033132

Source PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
TAS2R554429PubTator's text mininghttps://conductscience.org/library/genes/54429

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41201971

GET https://conductscience.org/api/papers/v1/41201971/references?page=2